Graphite Bio, Inc.

NASDAQ:GRPH

3.18 (USD) • At close March 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -124.651-101.052-70.76-68.373-0.109
Depreciation & Amortization 2.4072.3520.7340.1210
Deferred Income Tax 2.3580000
Stock Based Compensation 10.57413.5347.8710.1770
Change In Working Capital -39.223-7.208-2.4981.7090.01
Accounts Receivables 0-0.014-0.01400
Inventory 000.01400
Accounts Payables -2.3580.1941.8250.594-0.012
Other Working Capital -36.865-7.388-4.3231.1150.022
Other Non Cash Items 58.5284.39411.80157.6450.08
Operating Cash Flow -90.007-87.98-52.852-8.721-0.019
Investing Activities:
Investments In Property Plant And Equipment -10.856-6.594-5.74-1.5450
Acquisitions Net 1.9040.235000
Purchases Of Investments -28.129-405.519000
Sales Maturities Of Investments 263.427170.25000
Other Investing Activites 1.904-0.235000
Investing Cash Flow 226.346-241.863-5.74-1.5450
Financing Activities:
Debt Repayment 00000
Common Stock Issued 0.2570.676251.32330.0770
Common Stock Repurchased -0.067-0.079000
Dividends Paid 00000
Other Financing Activities 0.190.597417.46730.0770
Financing Cash Flow 0.190.597417.46730.0770
Other Information:
Effect Of Forex Changes On Cash 1.6020000
Net Change In Cash 138.131-329.246358.87519.811-0.019
Cash At End Of Period 185.86149.446378.69219.8170.006